Literature DB >> 23909015

[Targeted nanomedicine in diagnostics and therapy of neurological diseases].

Fodor Bertalan1, Barkai László, Valikovics Attila.   

Abstract

The incidence of neurological diseases increases. The up to date diagnostics and therapeutics approaches require the cost-effective and personalized solutions. The nanomedicine now, --and likely more in the future--opens a new horizon in the treatment of neurological diseases. The nano-size materials have several advantages that make it their use as drug delivery systems, and imaging agent. Very important aspect is that these materials can transfer across the blood-brain barrier. The functionalization and surface modification of nanomaterials enhances this effect. The authors summarize of neurological application of nanoparticles according to the current data. They provide an overview about the most common used nanomedical materials, targeted drug delivery mechanisms and nano-imaging opportunities.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23909015

Source DB:  PubMed          Journal:  Ideggyogy Sz        ISSN: 0019-1442            Impact factor:   0.427


  1 in total

1.  Investigations on agglomeration and haemocompatibility of vitamin E TPGS surface modified berberine chloride nanoparticles.

Authors:  Parameswara Rao Vuddanda; Vijayakumar Mahalingam Rajamanickam; Madhu Yaspal; Sanjay Singh
Journal:  Biomed Res Int       Date:  2014-08-04       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.